Stock Events

Stock Events

Candel Therapeutics (CADL) Q4 2025 Earnings

13NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.4

-0.22

-0.05

0.13

Details

Expected EPS

-0.185189

Actual EPS

-0.21

Surprise EPS

-0.02

Surprise Percent

+13.4%

Description

Candel Therapeutics (CADL) has reported earnings of -0.21 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.